Oral Guanabenz for Multiple Sclerosis
Clinical trial NCT02423083 · TERMINATED
Trial details
- NCT number
- NCT02423083
- Sponsor
- National Institute of Neurological Disorders and Stroke (NINDS)
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-04-21
- Primary completion
- 2017-10-30
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.